Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia

Kico Chan¹, Imogen Elsum¹, Judy Gold^{1

2}, Chloe Layton^{1

3}, Lisa Accadia^{1

3}, Mellissa Bryant^{1

3}, Jack Gunn¹, Filip Djordjevic^{1

4}, Isabelle Purcell⁵, Jane Dicka⁶, Martin Forrest⁵, Sione Crawford⁶, Margaret Hellard^{1

2

3

7}, Alisa Pedrana^{1

2}; Eliminate Hepatitis C Partnership

Affiliations

¹ Disease Elimination, Burnet Institute, Melbourne, Vic., Australia.
² Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia.
³ Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Vic., Australia.
⁴ Behaviours and Health Risks, Burnet Institute, Melbourne, Vic., Australia.
⁵ Hepatitis Victoria/LiverWELL, Melbourne, Vic., Australia.
⁶ Harm Reduction Victoria, Melbourne, Vic., Australia.
⁷ Doherty Institute and School of Population and Global Health, University of Melbourne, Melbourne, Vic., Australia.

Kico Chan et al. J Viral Hepat. 2021 Mar.

. 2021 Mar;28(3):569-572.

doi: 10.1111/jvh.13447. Epub 2020 Dec 12.

¹ Disease Elimination, Burnet Institute, Melbourne, Vic., Australia.
² Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia.
³ Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Vic., Australia.
⁴ Behaviours and Health Risks, Burnet Institute, Melbourne, Vic., Australia.
⁵ Hepatitis Victoria/LiverWELL, Melbourne, Vic., Australia.
⁶ Harm Reduction Victoria, Melbourne, Vic., Australia.
⁷ Doherty Institute and School of Population and Global Health, University of Melbourne, Melbourne, Vic., Australia.

No abstract available

Keywords: HCV infection; Hepatitis C; health promotion; incentives; people who inject drugs.

References

1. Khatun M, Ray RB. Mechanisms underlying hepatitis C virus-associated hepatic fibrosis. Cells. 2019;8(10):1249.
1. Das D, Pandya M. Recent advancement of direct-acting antiviral agents (DAAs) in hepatitis c therapy. Mini Rev Med Chem. 2018;18(7):584-596.
1. World Health Organization. Global Health Sector Strategies on Viral Hepatitis. 2016-2021. 2016. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed May 2020.
1. Hepatitis C Virus Infection Consensus Statement Working Group. Australian recommendations for the management of hepatitis C virus infection: a consensus statement. (September 2018). 2018. https://www.hepcguidelines.org.au/. Accessed May 2020.
1. Wade AJ, Doyle JS, Gane E, et al. Outcomes of treatment for hepatitis C in primary care, compared to hospital-based care: a randomized, controlled trial in people who inject drugs. Clin Infect Dis. 2020;70(9):1900-1906.